Amundi Pioneer Asset Management Inc. Has $5.60 Million Stake in West Pharmaceutical Services Inc. (WST)

Amundi Pioneer Asset Management Inc. lessened its holdings in West Pharmaceutical Services Inc. (NYSE:WST) by 8.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 57,118 shares of the medical instruments supplier’s stock after selling 4,936 shares during the quarter. Amundi Pioneer Asset Management Inc. owned about 0.08% of West Pharmaceutical Services worth $5,599,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the stock. State of Alaska Department of Revenue increased its holdings in West Pharmaceutical Services by 1.7% in the 4th quarter. State of Alaska Department of Revenue now owns 8,056 shares of the medical instruments supplier’s stock worth $789,000 after buying an additional 131 shares during the period. MetLife Investment Advisors LLC increased its holdings in West Pharmaceutical Services by 0.3% in the 4th quarter. MetLife Investment Advisors LLC now owns 45,170 shares of the medical instruments supplier’s stock worth $4,428,000 after buying an additional 148 shares during the period. First Hawaiian Bank increased its holdings in West Pharmaceutical Services by 6.7% in the 4th quarter. First Hawaiian Bank now owns 2,752 shares of the medical instruments supplier’s stock worth $270,000 after buying an additional 172 shares during the period. PNC Financial Services Group Inc. increased its holdings in West Pharmaceutical Services by 0.7% in the 4th quarter. PNC Financial Services Group Inc. now owns 23,952 shares of the medical instruments supplier’s stock worth $2,349,000 after buying an additional 173 shares during the period. Finally, Metropolitan Life Insurance Co. NY increased its holdings in West Pharmaceutical Services by 0.9% in the 4th quarter. Metropolitan Life Insurance Co. NY now owns 22,069 shares of the medical instruments supplier’s stock worth $2,163,000 after buying an additional 199 shares during the period. Institutional investors own 94.39% of the company’s stock.

WST has been the topic of a number of analyst reports. Zacks Investment Research cut shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research note on Friday, April 19th. William Blair initiated coverage on shares of West Pharmaceutical Services in a research note on Tuesday. They set an “outperform” rating and a $112.16 price objective on the stock.

Shares of NYSE WST traded up $0.01 during midday trading on Wednesday, reaching $115.21. 346,326 shares of the stock were exchanged, compared to its average volume of 445,818. The stock has a market capitalization of $8.22 billion, a price-to-earnings ratio of 41.00, a PEG ratio of 3.54 and a beta of 1.25. West Pharmaceutical Services Inc. has a twelve month low of $84.91 and a twelve month high of $125.09. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.15 and a quick ratio of 2.40.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, February 14th. The medical instruments supplier reported $0.73 EPS for the quarter, topping analysts’ consensus estimates of $0.72 by $0.01. West Pharmaceutical Services had a net margin of 12.05% and a return on equity of 15.89%. The business had revenue of $422.50 million for the quarter, compared to analysts’ expectations of $432.38 million. During the same quarter last year, the company earned $0.64 EPS. The business’s revenue was up 1.7% on a year-over-year basis. Analysts anticipate that West Pharmaceutical Services Inc. will post 2.85 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Wednesday, April 17th will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Tuesday, April 16th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.52%. West Pharmaceutical Services’s dividend payout ratio (DPR) is 21.35%.

ILLEGAL ACTIVITY WARNING: This piece of content was originally reported by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this piece of content on another website, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.baseballdailydigest.com/news/2019/04/24/amundi-pioneer-asset-management-inc-sells-4936-shares-of-west-pharmaceutical-services-inc-wst.html.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Further Reading: Cash Flow Analysis in Stock Selection

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.